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Abstract
Three pediatric patients with different illnesses leading to knee arthritis and large Baker cysts and
additional calf swelling are reported. Calf swelling was due to true popliteal venous thrombosis and
not to the much more common cause of pseudothrombophlebitis. Careful ultrasound examination
can differentiate these two causes of calf swelling. Even though all our patients had risk factors for
thrombophilia, we do not recommend routine thrombophilia work-up for all arthritis patients in
the absence of thrombosis.
Large Baker cysts-particularly following rupture-may lead
to calf swelling and pseudothrombophlebitis that has
been described in many adult and juvenile patients [1,2].
Pseudothrombophlebitis implies that symptoms of a
venous thrombosis such as calf swelling are present, but
not caused by thrombophlebitis. True popliteal venous
thrombosis has only rarely been reported [3]. We recently
saw 3 patients with different forms of juvenile arthritis
and Baker cysts without a prior personal or family history
of thrombotic events who developed popliteal venous
thrombosis and upon work-up following the thrombosis
had risk factors for thrombophilia.
Patient 1 was a 13-year old boy with a 9-year history of
systemic juvenile idiopathic arthritis who developed left
knee arthritis after a period of 18 months of disease remis-
sion off any medication. Several days later he also com-
plained of painful calf swelling. On ultrasound
examination a Baker cyst (52 × 28 × 24 mm) and 2 smaller
cysts were found as well as incomplete popliteal venous
thrombosis. During treatment with enoxaparin the
thrombus dissolved within 2 weeks, and enoxaparin was
stopped after 5 months. The knee arthritis improved with
naproxen and methotrexate and after intraarticular injec-
tion of triamcinolone hexacetonide. At last follow-up 18
months later, the patient felt entirely well without effu-
sion but a very small cyst remained.
Patient 2 was a 9-year-old girl with juvenile idiopathic oli-
goarthritis and 5 months of right knee arthritis treated
with naproxen who newly complained of painful calf
swelling. Sonography showed a 74 × 34 × 13 mm large
Baker cyst as well as an incomplete thrombosis of the pop-
liteal vein. With enoxaparin normal venous flow was rees-
tablished within 3 months and enoxaparin was then
stopped. The arthritis improved rapidly following intraar-
ticular injection of triamcinolone hexacetonide and con-
tinued naproxen. Nine months later the girl had no
complaints, and sonography found a smaller Baker cyst
and a very small effusion.
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Patient 3 was a 14-year old boy initially seen at another
hospital with right knee arthritis. He was HLA-B27-posi-
tive and had highly positive IgG antibody titers against
Borrelia burgdorferi. During 2 weeks of intravenous ceftri-
axone his arthritis disappeared, but a few days after the
end of antibiotic therapy he developed contralateral knee
arthritis and calf swelling. Sonography found a large Baker
cyst (86 × 12 mm) and complete popliteal venous throm-
bosis. He was treated with continuous intravenous
heparin and switched to phenprocoumone within a few
days, and his thrombosis disappeared within 6 weeks. He
also received naproxen. When we first saw the patient 6
weeks after onset of the thrombosis, his arthritis had
markedly improved, and the cyst could no longer be seen
on ultrasound. Phenprocoumone and naproxen were
both stopped 3 months after the onset of thrombosis, and
another 13 months later the patient was asymptomatic
and without evidence of joint effusion, cyst or thrombo-
sis.
A broad investigation for risk factors for thrombophilia
was performed in all 3 patients and risk factors found in
our patients are shown in Table 1. Each patient had sev-
eral risk factors. In particular, patient 2 had 2 known risk
factors for venous thrombosis with heterozygous muta-
tions in the prothrombin and the factor V genes. Other
risk factors such as the PAI-1 (plasminogen activator
inhibitor) and fibrinogen polymorphisms have been
shown to increase the risks of stroke or myocardial infarc-
tion, but may have contributed to the thrombotic events
in our patients. More common risk factors such as factor
V Leiden, deficiencies in proteins C or S or antiphosphol-
ipid-antibodies were not present in our patients. The
thrombophilia risk factors in our patients have not led us
to restrict their physical activitites.
In conclusion, large Baker cysts can be mechanical factors
contributing to popliteal vein thrombosis, at least in
patients with risk factors for thrombophilia. Patients with
large Baker cysts and calf swelling should receive careful
ultrasound evaluation for the possibility of true thrombo-
sis that could have been mistaken as pseudothrom-
bophlebitis. Since thrombosis remains rare in patients
with Baker cysts, we do not recommend routine throm-
bophilia work-up in the absence of thrombosis.
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Table 1: Thrombophilia risk factors present (+) or absent (-) in our patients. Only those risk factors present in at least one of our 
patients are shown.
Patient 1 Patient 2 Patient 3
Prothrombin G20210A mutation - + -
Factor V A4070G mutation* - + -
Lipoprotein (a) increase + + -
Methylenetetrahydrofolatereductase (MTHFR) mutation** + + +
PAI-1 4G/4G mutation + - +
β fibrinogen G455A mutation + + +
Lupus antibody2 +- -
Factor VIII increase3 -+ +
All mutations were heterozygous except for the homozygous MTHFR mutation A1298C in patient 1.
*This is not the factor V Leiden mutation.
**MTHFR mutations were homozygous A1298C in patient 1, heterozygous A1298C in patient 2 and C677T in patient 3.
PAI = Plasminogen Activator Inhibitor.
2Lupus antibody was an IgM against beta-2-glycoprotein.
3Factor VIII increases were around 200% of the expected and present at the time of thrombosis, but may also be explained as acute phase reaction.